Journal of Antimicrobial Chemotherapy

Differentiation of genotypic resistance profiles for amprenavir and lopinavir, a valuable aid for choice of therapy in protease inhibitor-experienced HIV-1-infected subjects
pp. 319-323(5)
Authors: Denise Paulsen; Robert Elston; Wendy Snowden; Margaret Tisdale; Lisa Ross

Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact
pp. 324-330(7)
Authors: Fausto Baldanti; Giuseppe Gerna

Properties and potential of ertapenem
pp. 331-344(14)
Authors: David M. Livermore; Armine M. Sefton; Geoffrey M. Scott

High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae
pp. 345-353(9)
Authors: Fiona Walsh; Joanne Willcock; Sebastian Amyes

Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression
pp. 354-358(5)
Authors: J. Ford; E. R. Meaden; P. G. Hoggard; M. Dalton; P. Newton; I. Williams; S. H. Khoo; D. J. Back

Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum
pp. 359-364(6)
Authors: Vera Hommer; Jutta Eichholz; Franz Petry

Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
pp. 365-370(6)
Authors: Estrella Martín-Mazuelos; Javier Pemán; Anastasio Valverde; Mónica Chaves; M. Carmen Serrano; Emilia Cantón

Comparative activity of telithromycin against typical community-acquired respiratory pathogens
pp. 371-374(4)
Authors: Astrid Buxbaum; Sabine Forsthuber; Wolfgang Graninger; Apostolos Georgopoulos

Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia
pp. 375-381(7)
Authors: Alessandra Arzese; Barbara Skerlavaj; Linda Tomasinsig; Renato Gennaro; Margherita Zanetti

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS)
pp. 382-388(7)
Authors: George G. Zhanel; Nancy M. Laing; Kim A. Nichol; Lorraine P. Palatnick; Ayman Noreddin; Tamiko Hisanaga; Jack L. Johnson; Daryl J. Hoban

Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model
pp. 389-396(8)
Authors: Trupti A. Gaonkar; Shanta M. Modak

Characterization of pentamidine excretion in the isolated perfused rat kidney
pp. 397-404(8)
Authors: Nagaraju R. Poola; Michelle Kalis; Fotios M. Plakogiannis; David R. Taft

Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model
pp. 405-411(7)
Authors: Prachi K. Dandekar; Pamela R. Tessier; Peter Williams; Charlie H. Nightingale; David P. Nicolau

In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments
pp. 412-418(7)
Authors: Nilton Lincopan; Elsa M. Mamizuka; Ana M. Carmona-Ribeiro

Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice
pp. 419-427(9)
Authors: M. S. Espuelas; P. Legrand; M. A. Campanero; M. Appel; M. Chéron; C. Gamazo; G. Barratt; J. M. Irache

Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis
pp. 428-434(7)
Authors: Martin J. Becker; Siem de Marie; Marcel H. A. M. Fens; Henri A. Verbrugh; Irma A. J. M. Bakker-Woudenberg

Gatifloxacin and the elderly: pharmacokinetic–pharmacodynamic rationale for a potential age-related dose reduction
pp. 435-440(6)
Authors: Paul G. Ambrose; Sujata M. Bhavnani; Brenda B. Cirincione; Marion Piedmonte; Thaddeus H. Grasela

Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction
pp. 441-449(9)
Authors: Alejandro G. Schijman; Jaime Altcheh; Juan M. Burgos; Miguel Biancardi; Margarita Bisio; Mariano J. Levin; Héctor Freilij

Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects
pp. 450-456(7)
Authors: Mark H. Gotfried; Larry H. Danziger; Keith A. Rodvold

Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa
pp. 457-463(7)
Authors: Joseph A. Paladino; Jenna L. Sunderlin; Alan Forrest; Jerome J. Schentag

Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study
pp. 464-468(5)
Authors: Fernando Laguna; Sebastián Videla; Manuel E. Jiménez-Mejías; Guillem Sirera; Julián Torre-Cisneros; Esteban Ribera; Dolores Prados; Bonaventura Clotet; Mariano Sust; Rogelio López-Vélez; Jorge Alvar

Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media
pp. 469-472(4)
Authors: Michael W. Dunne; Thomas Latiolais; Barnett Lewis; Bruce Pistorius; Gerald Bottenfield; William H. Moore; Anne Garrett; Tracy D. Stewart; Jeffrey Aoki; Craig Spiegel; David Boettger; Anne Shemer

A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs
pp. 473-476(4)
Authors: Roly D. Gosling; Leonid Heifets; Stephen H. Gillespie

Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii
pp. 477-480(4)
Authors: Anna Ribera; Ignasi Roca; Joaquim Ruiz; Isidre Gibert; Jordi Vila

Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis
pp. 481-484(4)
Authors: M. L. Peterson; J. C. Rotschafer; L. J. V. Piddock

Clonal diversity among erythromycin-resistant -haemolytic Streptococcus isolates in La Rioja, Spain
pp. 485-488(4)
Authors: A. Portillo; M. J. Gastañares; F. Ruiz-Larrea; C. Torres

Phenotypic and genotypic characterization of antimicrobial resistance in German Escherichia coli isolates from cattle, swine and poultry
pp. 489-492(4)
Authors: Beatriz Guerra; Ernst Junker; Andreas Schroeter; Burkhard Malorny; Simone Lehmann; Reiner Helmuth

Diversity of TEM-52 extended-spectrum -lactamase-producing non-typhoidal Salmonella isolates in Korea
pp. 493-496(4)
Authors: Kyungwon Lee; Dongeun Yong; Jong Hwa Yum; Ho Hoon Kim; Yunsop Chong

In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae
pp. 497-499(3)
Authors: Naoyuki Miyashita; Hiroshi Fukano; Koichiro Yoshida; Yoshihito Niki; Toshiharu Matsushima

Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria
pp. 500-502(3)
Authors: Laura J. V. Piddock; M. M. Johnson; Mark A. Webber

Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae
pp. 503-506(4)
Author: Mark W. Garrison

Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals
pp. 507-510(4)
Authors: L. P. Randall; A. M. Ridley; S. W. Cooles; M. Sharma; A. R. Sayers; L. Pumbwe; D. G. Newell; L. J. V. Piddock; M. J. Woodward

Pharmacodynamics of linezolid in a clinical isolate of Streptococcus pneumoniae genetically modified to express lux genes
pp. 511-513(3)
Authors: Habib M. Alloush; Vyvyan Salisbury; Roger J. Lewis; Alasdair P. MacGowan

Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides
pp. 514-517(4)
Authors: Joan Gavaldà; Pedro López Onrubia; María Teresa Martín Gómez; Xavier Gomis; José Luis Ramírez; Oscar Len; Dolors Rodríguez; Manuel Crespo; Isabel Ruíz; Albert Pahissa

Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection
pp. 518-521(4)
Authors: Sutep Jaruratanasirikul; Somchai Sriwiriyajan

Mastic gum has no effect on Helicobacter pylori load in vivo
pp. 522-523(2)
Authors: James R. Bebb; Nathalie Bailey-Flitter; Dlawer Ala’Aldeen; John C. Atherton

Significance of macrolide resistance in Streptococcus pneumoniae
pp. 524-525(2)
Authors: Eric L. Nuermberger; William R. Bishai

Reply
pp. 525-525(1)
Authors: J. Verhaegen; W. Peetermans; L. Verbist

Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodology
pp. 526-527(2)
Authors: J. M. Andrews; J. P. Ashby; G. Jevons; R. Wise

Bactericidal activity of levofloxacin against Mycoplasma pneumoniae
pp. 527-528(2)
Authors: Lynn B. Duffy; Donna M. Crabb; Xue Bing; Ken B. Waites

Detection of CTX-M-15 extended-spectrum -lactamase in the United Kingdom
pp. 528-529(2)
Authors: Shazad Mushtaq; Neil Woodford; Nicola Potz; David M. Livermore

Occurrence and spread of SHV extended-spectrum -lactamase-producing Klebsiella pneumoniae isolates in Curaçao
pp. 530-532(3)
Authors: Mireille van Westreenen; Armand Paauw; Ad C. Fluit; Sylvain Brisse; Willemien van Dijk; Jan Verhoef

Absence of vancomycin-resistant enterococci (VRE) in companion dogs in the conurbation of Parkstad Limburg, The Netherlands
pp. 532-532(1)
Authors: J. H. T. Wagenvoort; D. M. T. Burgers; T. H. C. Wagenvoort; E. Burgers

Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit
pp. 533-534(2)
Authors: Jorge Cepeda; Samantha Hayman; Tony Whitehouse; Christopher C. Kibbler; David Livermore; Mervyn Singer; A. Peter R. Wilson

Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum
pp. 535-535(1)
Authors: Vera Hommer; Jutta Eichholz; Franz Petry

Intrapulmonary penetration of linezolid
pp. 536-536(1)
Authors: David Honeybourne; Caroline Tobin; Gail Jevons; Jenny Andrews; Richard Wise